YARW · Yarrow Bioscience, Inc.
$33.00
+2.55 (+8.37%)
At close · Jul 30
Market Cap
$952.56M
Shares
33.35M
Yarrow Bioscience, Inc. Earnings Call Transcripts
Every quarterly earnings call for Yarrow Bioscience, Inc. (YARW) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼46.5%
$2.29M
−$11.57M
'21 Q4
22-03-17
▼95.7%
$178,000
$4.67M
'22 Q1
22-05-17
▼97%
$126,000
−$8.48M
'22 Q2
22-08-12
▼95.9%
$167,000
−$9.46M
'22 Q3
22-11-10
▼99.7%
$6,000
−$9.95M
'22 Q4
23-03-09
▼44.4%
$99,000
−$5.62M
'23 Q1
23-05-11
▲7.1%
$135,000
−$10.06M
'23 Q2
23-08-14
▼31.7%
$114,000
−$6.58M
'23 Q3
23-11-13
▲1166.7%
$76,000
−$6.19M
'23 Q4
24-02-29
▼1%
$98,000
−$6.25M
'24 Q1
24-05-09
▲46.7%
$198,000
−$9.41M
'24 Q2
24-08-14
▲6.1%
$121,000
−$12.16M
'24 Q3
24-11-07
▲10.5%
$84,000
−$12.02M
'24 Q4
25-03-06
▲106.1%
$202,000
−$8.61M
'25 Q1
25-05-08
LATEST
▼65.2%
$69,000
−$5.75M
'25 Q2
25-07-30
Earnings call
FY25 · Q3
2025-11-06
VYNE Therapeutics Inc. Q3 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
VYNE Therapeutics Inc. Q2 FY2025 Earnings Call
Revenue
$69,000
▼ 65.2% YoY Diluted EPS
$-6.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Capital Markets Day
Investor event
2025-07-09
VYNE Investor Relations Presentation
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q1
2025-05-08
VYNE Therapeutics Inc. Q1 FY2025 Earnings Call
Revenue
$202,000
▲ 106.1% YoY Diluted EPS
$-10.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2025-03-20
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q4
2025-03-06
VYNE Therapeutics Inc. Q4 FY2024 Earnings Call
Revenue
$84,000*
▲ 10.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
VYNE Therapeutics Inc. Q3 FY2024 Earnings Call
Revenue
$121,000
▲ 6.1% YoY Diluted EPS
$-14.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
VYNE Therapeutics Inc. Q2 FY2024 Earnings Call
Revenue
$198,000
▲ 46.7% YoY Diluted EPS
$-11.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
VYNE Therapeutics Inc. Q1 FY2024 Earnings Call
Revenue
$98,000
▼ 1% YoY Diluted EPS
$-7.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
VYNE Therapeutics Inc. Q4 FY2023 Earnings Call
Revenue
$76,000*
▲ 1166.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
VYNE Therapeutics Inc. Q3 FY2023 Earnings Call
Revenue
$114,000
▼ 31.7% YoY Diluted EPS
$-100.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
VYNE Therapeutics Inc. Q2 FY2023 Earnings Call
Revenue
$135,000
▲ 7.1% YoY Diluted EPS
$-154.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
VYNE Therapeutics Inc. Q1 FY2023 Earnings Call
Revenue
$99,000
▼ 44.4% YoY Diluted EPS
$-87.00
▼ 220.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-09
VYNE Therapeutics Inc. Q4 FY2022 Earnings Call
Revenue
$6,000*
▼ 99.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
VYNE Therapeutics Inc. Q3 FY2022 Earnings Call
Revenue
$167,000
▼ 95.9% YoY Diluted EPS
$-144.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
VYNE Therapeutics Inc. Q2 FY2022 Earnings Call
Revenue
$126,000
▼ 97% YoY Diluted EPS
$-135.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-17
VYNE Therapeutics Inc. Q1 FY2022 Earnings Call
Revenue
$178,000
▼ 95.7% YoY Diluted EPS
$72.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-17
VYNE Therapeutics Inc. Q4 FY2021 Earnings Call
Revenue
$2.29M*
▼ 46.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
VYNE Therapeutics Inc. Q3 FY2021 Earnings Call
Revenue
$4.09M
▲ 25% YoY Diluted EPS
$-369.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
VYNE Therapeutics Inc. Q2 FY2021 Earnings Call
Revenue
$4.26M
▼ 63.6% YoY Diluted EPS
$-351.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
VYNE Therapeutics Inc. Q1 FY2021 Earnings Call
Revenue
$4.12M
▲ 135.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
VYNE Therapeutics Inc. Q3 FY2020 Earnings Call
Revenue
$3.27M
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
VYNE Therapeutics Inc. Q2 FY2020 Earnings Call
Revenue
$11.69M
▲ 15.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
VYNE Therapeutics Inc. Q1 FY2020 Earnings Call
Revenue
$1.75M
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 earnings calls